Z-Pak linked to sudden Heart Attacks

Azithromycin (Zithromax or Z-Pak) is an antibiotic in the macrolide drug class commonly prescribed to those with sinus infection, bronchitis or pneumonia. An observational study was published on May 17, 2012 in the New England Journal of Medicine observing Medicaid patients on azithromycin for a 5 day course. The U.S. Food and Drug Administration made an announcement reminding clinicians that QT prolongation can trigger a potentially fatal heart rhythm called torsades de pointe, which has been linked to azithromycin as well as other drugs in the macrolide class. Macrolides have been under FDA radar since 2011. In March 2012, revisions were made to the drug’s warnings and precautions of the extended release tabs and oral suspension to mention reports of QT prolongation and risk for torsades. The FDA reminds clinicians to avoid prescribing the antibiotic to those with known prolongation of the QT interval, patients with low potassium, or those currently on medications known to cause QT prolongation. The law firm of Rudolph F.X. Migliore, P.C. is investigating cases of those who have been on Zithromax (Z-Pak) and have suffered a sudden or fatal heart attack. If you or a loved one may have been injured by Zithromax, call our office for a free case evaluation at 631-543-3663. Rudolph F.X. Migliore, P.C. works with nationally recognized co-counsel to obtain major verdicts and settlements. With over three decades of experience, the firm is well positioned to help those injured by Zithromax. Call 631-543-3663 or visit Migliorelaw.com .